Impact of Immune Checkpoint Inhibitors on Enfortumab Vedotin Cutaneous Toxicity: a systematic clinicopathologic review
Published: 26 May 2026| Version 1 | DOI: 10.17632/5mkd9xfdzt.1
Contributor:
Yassaman ErfaniDescription
Supplementary material
Files
Categories
Dermatology, Enfortumab Vedotin, Immune Checkpoint Inhibitor